Clinical trials are a critical component of medical research, involving the testing of pharmaceutical drugs, medical devices, or other treatments on human participants to evaluate their efficacy and safety. These
The recent rise of the “tripledemic” – the simultaneous spread of the influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV) – is posing significant risks, especially to older adults and
A recent study published in the journal Nature analyzed early cellular response dynamics to SARS-CoV-2 in seronegative individuals using single-cell multi-omics profiling, identifying key cellular states and immune responses associated
Highlights · hVIVO to enrol up to 1,000 healthy volunteers as part of a multicenter field study testing an influenza drug candidate, with hVIVO selected as the sole UK clinical site · Largest field
Fifty years ago this month, India experienced its final seasonal smallpox epidemic. Nearly 200,000 infections were recorded, resulting in over 30,000 deaths. By May 1975, the last case of smallpox
A travellers’ vaccine is administered to individuals from non-endemic regions before they travel to areas where certain diseases are prevalent. These vaccines are crucial for travel medicine, protecting travellers and
Infectious diseases account for 7% of deaths in the UK and cost the economy £30 billion annually, significantly burdening the NHS and affecting productivity and wellbeing. Human challenge trials (HCTs),
In June 2024, hVIVO announced a £2.5 million contract with a mid-sized pharmaceutical company to launch an Omicron characterisation study. This study aims to determine a dose of hVIVO’s Omicron
Shares in the London and Dublin-listed life sciences firm hVivo saw a rise on Monday following the announcement of its inaugural Covid vaccine-related contract. Formerly known as Open Orphan, the
Hvivo, a pharmaceutical services company listed on the Dublin and London stock exchanges, has secured a £2.5 million (€2.9m) contract with a mid-sized pharmaceutical company to start a Covid-19 characterisation
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
